Truemeds in talks to acquire DealShare at $90 Mn, a 95% cut from its $1.7 Bn peak

Fact

Ecommerce unicorn DealShare is reportedly in advanced talks to be acquired by online pharmacy Truemeds through a share-swap deal that would value DealShare at a little over $90 Mn, per the Economic Times, with Entrackr first reporting the talks were underway. Truemeds is expected to issue shares to DealShare's investors at Truemeds' own valuation of roughly $600 Mn; WestBridge Capital is a common investor in both startups. The proposed price is only marginally above DealShare's own cash balance of over $90 Mn, meaning the deal is effectively priced on DealShare's cash reserves rather than its operating business, letting Truemeds access those funds without an upfront cash payment. DealShare hit unicorn status in 2022 at a $1.7 Bn valuation after a $165 Mn Series E from Tiger Global, Alpha Wave and Kora Investment, plus a later $45 Mn from the Abu Dhabi Investment Authority. Since then it has shut its B2B vertical, laid off 100+ employees in 2023, shifted headquarters from Bengaluru to Delhi NCR, and lost its entire founding team, with last remaining cofounder Rajat Shikhar departing in December 2025. Revenue fell from ₹1,963 Cr in FY23 to ₹499 Cr in FY24 to ₹432 Cr in FY25, while losses narrowed from ₹167 Cr to ₹87.65 Cr over the same stretch. Truemeds itself has raised over $175 Mn to date, including an $85 Mn Series C last year at a valuation above $400 Mn.

Interpretation

A deal priced almost exactly at the target's cash balance, with no premium for the operating business, is the market's way of saying DealShare's ecommerce operations in smaller cities carry close to zero standalone value once its founding team and growth engine are gone.

Action

Founders running inventory-led, Tier II-III-focused ecommerce should treat this as the going rate for a distressed-but-still-cash-rich exit, and negotiate on cash-balance-plus-strategic-value terms early, before burn erodes the cash cushion that's currently the only real asset on the table.

Watch next

Whether DealShare's brand and operations continue under Truemeds or get wound down entirely, and whether Truemeds' healthtech distribution network actually benefits from DealShare's smaller-city sourcing and logistics footprint.

Fact

Chennai-based GRT Jewellers has signed a share purchase agreement with the promoters of listed jewellery retailer Tribhovandas Bhimji Zaveri (TBZ) to acquire a 74.12% stake for up to ₹1,033.71 Cr, per Reuters, with a follow-on open offer for another 26% of TBZ's equity to comply with SEBI takeover rules. TBZ traces its roots to 1864 in Mumbai's Zaveri Bazaar and now runs 37 stores across India; its shares closed 1.19% higher at ₹305.45 ahead of the announcement, valuing the company at ₹2,038.29 Cr. GRT, founded in 1964, operates 68 stores across India plus one in Singapore, with over 12,000 employees, roughly 650,000 sq ft of retail space and a customer base above 15 million, spanning gold, silver, diamond and platinum jewellery under its own brand and sub-brands Oriana and Silvana. GRT managing director G.R. Radhakrishnan called the deal “truly transformative,” while TBZ chairman Shrikant Zaveri said the fifth-generation family business would be in “the absolute best hands” with GRT.

Interpretation

A 162-year-old, single-heritage jeweller selling majority control to a 62-year-old multi-state chain, rather than raising capital or merging as equals, signals that scale and pan-India retail infrastructure now matter more than brand heritage alone in organised jewellery retail.

Action

D2C and omnichannel jewellery brands should treat GRT-TBZ as a template for exit economics in the category, heritage and customer relationships get priced as complementary assets to an acquirer's retail capability, not as standalone premium value.

Watch next

Whether TBZ retains its brand identity and store network under GRT or gets folded into GRT's existing retail formats, and how the SEBI-mandated 26% open offer prices relative to the promoter deal.

Fact

After deferring a $7 Bn IPO in July over investor concerns about cash burn and the industry's lowest average order value (₹387, versus Blinkit's ₹665-669 and Instamart's ₹700 in FY26), Zepto has raised its free-delivery threshold in stages from ₹99 to ₹149 to now ₹199 in normal hours (up to ₹299 at peak demand), pulled back blanket cashbacks, paused aggressive dark-store expansion in metros, and revived a paid loyalty tier, Zepto Club, at ₹99/month offering 5% cashback, redeemable Zepto coins and priority service. It is also pushing premium and gourmet grocery through a new Select tab. Bernstein Research pegs Zepto's current cash runway at roughly 1.3 years and estimates platform discounts have already fallen from 18-20% of MRP at IPO-filing time to 14-16% now. Rivals Blinkit and Instamart already sat at ₹199 free-delivery thresholds; Zepto's own aggressive ₹99 threshold in 2025 had forced the wider industry back into a discount war.

Interpretation

Converging on the same free-delivery threshold as Blinkit and Instamart, after being the outlier that started the discount war, suggests Zepto is no longer trying to win quick commerce on price, it's trying to survive long enough to prove profitability before its next fundraising attempt.

Action

D2C brands selling through quick commerce should expect shrinking platform-funded promotional budgets from Zepto specifically through the festive season, and should model direct-to-consumer or Blinkit/Instamart-only promotional strategies as a hedge.

Watch next

Whether Zepto's Q2 FY27 numbers show the free-delivery threshold hikes actually improving basket size and burn, and whether the paid Zepto Club gains meaningful adoption before its next IPO attempt.

Fact

BNP Paribas Financial Markets, Société Générale and US hedge fund Millennium Management (via its affiliate Integrated Core Strategies) together offloaded Lenskart shares worth ₹2,670.2 Cr through multiple bulk deals on the NSE. BNP Paribas sold 1.3 Cr shares at ₹662.22 apiece for ₹855 Cr, Société Générale sold 1.4 Cr shares at ₹661.5 each for ₹930.8 Cr, and Millennium sold the remainder via its Asia-based affiliate. None of the three are known long-term strategic Lenskart investors; the sales read as institutional profit-booking rather than a strategic-exit signal.

Interpretation

Multiple unrelated financial institutions trimming Lenskart positions in the same window, at prices still comfortably above issue price, points to routine post-listing profit-taking rather than any shared concern about the company's fundamentals.

Action

D2C brands benchmarking their own IPO comps against Lenskart should separate this kind of institutional block-deal churn from operational signal, and watch promoter or anchor-investor lock-up expiries instead for a cleaner read on real conviction.

Watch next

Whether Lenskart's stock holds its current level as more lock-up tranches free up over the coming quarters, and whether any of the sellers re-enter at a lower price.

Fact

Pernia's Pop Up Shop parent Purple Style Labs' IPO was subscribed only 8% by the end of Day 1, with bids for 5.59 Lakh shares against 68.50 Lakh shares on offer. Retail investors covered 39% of their quota (4.85 Lakh of 12.45 Lakh shares), while non-institutional investors bid for just 74,126 of the 18.68 Lakh shares reserved for them. The company had priced its IPO band at ₹546-575 and had flagged a 51.5% widening FY26 loss ahead of listing; it had separately raised ₹306 Cr from anchor investors in the run-up to the offer.

Interpretation

Retail and non-institutional investors sitting out almost entirely on Day 1, for an IPO that already priced in a widening loss, suggests public-market appetite for loss-making, luxury-adjacent fashion platforms remains thin even when the anchor book looks healthy.

Action

D2C fashion and luxury-retail brands eyeing a public listing should treat anchor-round enthusiasm and retail-investor demand as separate signals, don't assume a well-subscribed anchor book de-risks the retail tranche.

Watch next

Whether institutional bidding on Day 2-3 rescues the overall subscription number, and where the issue finally lists relative to its ₹546-575 band.

Fact

UPI processed 24.51 Bn transactions worth ₹29.82 Lakh Cr in August 2026, per NPCI data, up nearly 4% from July's 23.66 Bn transactions and up 22% year-on-year from 20.01 Bn in August 2025. Transaction value dipped marginally from July's ₹29.88 Lakh Cr even as volume rose, meaning the average ticket size continued to shrink. Average daily transaction count rose to 791 Mn from 763 Mn, with average daily value effectively flat.

Interpretation

Volume climbing while per-transaction value declines shows UPI's growth is increasingly coming from smaller, more frequent payments, exactly the pattern quick-commerce and low-ticket D2C checkout flows produce, rather than from bigger-ticket purchases.

Action

D2C brands relying on UPI as their primary checkout method should watch average transaction value trends in their own numbers against this national trend, a declining ticket size industry-wide makes it harder to tell whether a brand's own falling AOV is company-specific or macro.

Watch next

Whether the festive season pushes UPI's average transaction value back up, and whether NPCI's planned AutoPay mandate portability, flagged in Edition 069, shows a measurable bump in recurring-payment volumes once live.

Fact

The maker of Old Monk rum has agreed to revise its product labels after the Bombay High Court questioned its “7 years old blended” and “very old vatted” descriptors, with a bench of Acting Chief Justice Ravindra V Ghuge and Justice Gautam Ankhad noting the wording could mislead consumers into thinking the entire spirit was aged seven years; the court also flagged that some label text was “so small that nobody can read.” FSSAI's investigation had found the labelled XXX variant was built mostly from unaged neutral spirit, with matured rum making up under 5% of the blend, in violation of Food Safety and Standards (Alcoholic Beverages) Regulations, 2018, which require an age claim to reflect the youngest spirit in a blend, not the oldest. The case follows an August 3 FSSAI order halting sales of select variants across six major whisky and rum brands, part of a broader FSSAI enforcement push running through 2026.

Interpretation

A near-160-year-old legacy FMCG brand agreeing to relabel rather than fight the finding in court signals that India's alcoholic-beverage labelling enforcement has moved from selective warnings to precedent-setting compliance actions the whole category will now have to match.

Action

D2C and legacy FMCG brands making any age, origin or composition claim on packaging should audit those claims against the youngest-ingredient standard now, proactively, rather than waiting for an FSSAI order or court notice to force a relabel.

Watch next

Whether the other five brands named in FSSAI's August 3 order follow Old Monk's lead and settle by relabelling, or continue contesting the enforcement action in court.